The impact of obstructive sleep apnea on endothelial function during weight loss in an obese pediatric population

Sofie Jacobs1, Emilie Mylemans1, Marijke Ysebaert1

  • 1Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Sleep Medicine
|August 30, 2021
PubMed

Insights

Weight loss in obese children improves blood vessel function. However, obstructive sleep apnea (OSA) can limit these improvements, highlighting the need for integrated treatment approaches.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Sleep Medicine

Background:

  • Childhood obesity is a growing concern, linked to serious health issues like obstructive sleep apnea (OSA) and cardiovascular problems.
  • Endothelial dysfunction, a precursor to cardiovascular disease, is associated with both obesity and OSA in children.

Purpose of the Study:

  • To assess how weight loss impacts endothelial function and OSA in obese children.
  • To determine if improvements in endothelial function correlate with better OSA outcomes.

Main Methods:

  • Obese children (8-18 years) joined a 12-month weight loss program.
  • Endothelial function and anthropometry were measured at baseline, 10 months, and 18 months.
  • Sleep screening for OSA was conducted at baseline and repeated at 10 months if initially diagnosed.

Main Results:

  • Weight loss significantly improved endothelial function (shorter time to peak response, higher reactive hyperemia index) in obese children.
  • Obstructive sleep apnea (OSA) was present in 67% of participants at baseline.
  • Residual OSA after weight loss was associated with poorer endothelial function and less improvement.

Conclusions:

  • Weight loss effectively enhances endothelial function in obese children.
  • The presence of obstructive sleep apnea (OSA) can impede the full benefits of weight loss on endothelial function.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
242
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
30
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
30
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
30
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
741
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
317